3月3日,Madrigal Pharmaceuticals, Inc.(MDGL.US)公布财报,公告显示公司2024财年净利润为-4.66亿美元,同比减少24.60%;其中营业收入为1.80亿美元,每股基本收益为-21.90美元。从资产负债表来看,Madrigal Pharmaceuticals, Inc.(MDGL.US)总负债2.88亿美元,其中短期债务983000.00美元,资产负债比为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.